MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BBOT — BridgeBio Oncology Therapeutics, Inc. Common Stock
NasdaqBridgeBio Oncology Therapeutics, Inc. Common Stock
$3.89
-0.05(-1.27%)
- O
- 3.97
- H
- 4.05
- L
- 3.88
- V
- 485.75K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About BBOT
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateAug 12, 2025
Employees88
Stock ExchangeNasdaq
Ticker SymbolBBOT
Websitehttps://www.bridgebio.com
Key Financial Statistics
| Market Cap | $316.69M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $3.79 - $14.87 |
| 52-Week Avg Volume | 345.4K |
| VWAP | $3.97 |
| Transactions | 6,701 |
| Total Recorded Bars | 292 days |